258
Views
9
CrossRef citations to date
0
Altmetric
Research Methods and Statistics

A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis

, , , , , & show all
Pages 63-70 | Received 28 Jan 2016, Accepted 18 Jul 2016, Published online: 16 Dec 2016

References

  • Pressman AR, Avins AL, Hubbard A, et al. A comparison of two worlds: how does Bayes hold up to the status quo for the analysis of clinical trials? Contemp Clin Trials 2011;32:561–568.
  • Moatti M, Zohar S, Facon T, et al. Modeling of experts’ divergent prior beliefs for a sequential phase III clinical trial. Clin Trials 2013;10:505–514.
  • Austin PC, Brunner LJ, Hux JE. Bayeswatch: an overview of Bayesian statistics. J Eval Clin Pract 2002;8:277–286.
  • Brophy JM, Joseph L. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA 1995;273:871–875.
  • Abrams K, Ashby D, Errington D. Simple Bayesian analysis in clinical trials: a tutorial. Control Clin Trials 1994;15:349–359.
  • Lewis RJ, Wears RL. An introduction to the Bayesian analysis of clinical trials. Ann Emerg Med 1993;22:1328–1336.
  • Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials. J R Stat Soc a Stat 1994;157:357–387.
  • Chaloner K, Rhame FS. Quantifying and documenting prior beliefs in clinical trials. Stat Med 2001;20:581–600.
  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844–848.
  • Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492–513.
  • Galor A, Jabs DA, Leder HA, et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 2008;115:1826–1832.
  • Bom S, Zamiri P, Lightman S. Use of methotrexate in the management of sight-threatening uveitis. Ocul Immunol Inflamm 2001;9:35–40.
  • Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005;32:362–365.
  • Siepmann K, Huber M, Stubiger N, et al. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol 2006;244:788–794.
  • Teoh SC, Hogan AC, Dick AD, et al. Mycophenolate mofetil for the treatment of uveitis. Am J Ophthalmol 2008;146:752–760.
  • Rathinam SR, Babu M, Thundikandy R, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology 2014;121:1863–1870.
  • Lee PM. Bayesian statistics: an introduction, 3rd ed. London: Arnold Publishers, 2004.
  • See CW, Srinivasan M, Saravanan S, et al. Prior elicitation and Bayesian analysis of the steroids for corneal ulcers trial. Ophthalmic Epidemiol 2012;19:407–413.
  • Sun CQ, Prajna NV, Krishnan T, et al. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Invest Ophthalmol Vis Sci 2013;54:4167–4173.
  • Hiance A, Chevret S, Levy V. A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial. J Clin Epidemiol 2009;62:431–437.
  • Johnson SR, Tomlinson GA, Hawker GA, et al. Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol 2010;63:355–369.
  • Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect 2012;2:21–28.
  • Samson CM, Waheed N, Baltatzis S, et al. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001;108:1134–1139.
  • Baltatzis S, Tufail F, Yu EN, et al. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003;110:1061–1065.
  • Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005;112:1472–1477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.